Media Coverage
BARDA provides Osivax with $19.5 million for universal flu vaccine
•
September 1, 2025
France’s Osivax wins $19.5M BARDA award for universal flu vaccine
•
August 26, 2025
France launches trial for a groundbreaking broad-spectrum coronavirus vaccine
•
February 16, 2024
Vers un vaccin efficace contre tous les variants du SARS-CoV2 ?
•
September 15, 2023
Les quatre domaines d’excellence de la French Tech
•
September 4, 2023
Biopharma Public Opinion, Pricing, Politics
•
December 21, 2022
Osivax is designing future-proof influenza and Covid vaccines
•
November 21, 2022
Osivax gets €10M influenza vaccine grant
•
June 23, 2022
Covid-19 : à la recherche des vaccins de nouvelle génération
•
February 22, 2022
14 drug discovery startups to watch, according to top VCs
•
January 31, 2022
Les six projets de vaccins français contre le Covid-19 les plus avancés
•
September 6, 2021
Covid : Osivax, cette biotech lyonnaise à la recherche du “vaccin universel”
•
February 16, 2021
Companies to watch: Osivax
•
October 1, 2020
Can Covid-19 Vaccines Keep up with an Evolving Virus?
•
August 27, 2020
RTBF – Une société biotech française séduite par Liège
•
July 11, 2019
European Biotechnology – €8M for universal flu vaccine
•
July 11, 2019
LABIOTECH.eu – The Top 10 Biotechs You’ll Find in Lyon
•
July 10, 2019
FinSMEs – Osivax Raises €8M in Series A Funding
•
July 10, 2019